Replies to post #2222 on Skye Bioscience Inc (SKYE)

[afterhoursearnings]

Bingo...traffic has picked up beavily from where it used to be...another month of upwards trajectory and traders may pick up on the fact that this could run hard with the right buys and we are off to the races imo...so undervalued here..buying every chance i get

[DarrenE]

Yeah I have been following these boards for a few weeks, if Schneider bros are in for 20 million at .30 , and .30 has virtually been its floor over its existence, then we're on pretty solid ground as far as speculatives go. I was just wondering if anyone has any thoughts on the strategy of InMed (also a biotech) vs Nemus. InMed is a trader's dream if you hit the right points on its manipulated roller coaster, but it appears Nemus has very little movement going on for whatever reason. I love the fact that Nemus' CEO is aggressively pushing for uplisting, hopefully that can happen soon and get folks' attention for a long surge. Feels odd that we all appear to know its upside, but the analysts appear to be behind...and on the flip side, part of me wonders if InMed is just existing for trading flips, as opposed to actual drug realization.

PS: it's also eerie how dead silent InMed boards have been, especially considering it just shot up 10+ cents (again).

Ah, the joy of spec stocks!